Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 44
Filter
Add more filters

Country/Region as subject
Publication year range
1.
Nutrients ; 13(4)2021 Apr 06.
Article in English | MEDLINE | ID: mdl-33917279

ABSTRACT

BACKGROUND: Age predisposes individuals to a myriad of disorders involving inflammation; this includes stress-related neuropsychiatric disorders such as depression and anxiety, and neurodegenerative diseases. Obesity can further exacerbate these effects in the brain. We investigated whether an inexpensive dietary supplement, s-adenosylmethionine (SAMe), could improve age- and/or obesity-related inflammatory and affective measures in the hippocampus. METHODS: Mice were placed on their diets at six weeks of age and then aged to 14 months, receiving SAMe (0.1 g/kg of food) for the final six weeks of the experiment. Prior to tissue collection, mice were tested for anxiety-like behaviors in the open field test and for metabolic outcomes related to type 2 diabetes. RESULTS: SAMe treatment significantly improved outcomes in aged control mice, where fasting glucose decreased, liver glutathione levels increased, and hippocampal microglia morphology improved. SAMe increased transforming growth factor ß-1 mRNA in both control mice, potentially accounting for improved microglial outcomes. Obese mice demonstrated increased anxiety-like behavior, where SAMe improved some, but not all, open field measures. CONCLUSIONS: In summary, SAMe boosted antioxidant levels, improved diabetic measures, and hippocampal inflammatory and behavioral outcomes in aged mice. The effects of SAMe in obese mice were more subdued, but it could still provide some positive outcomes for obese individuals dealing with anxiety and having difficulty changing their behaviors to improve health outcomes.


Subject(s)
Aging/immunology , Anxiety/diet therapy , Hippocampus/drug effects , Obesity/complications , S-Adenosylmethionine/administration & dosage , Animals , Anxiety/diagnosis , Anxiety/immunology , Anxiety/metabolism , Blood Glucose/drug effects , Blood Glucose/metabolism , Diet, High-Fat/adverse effects , Dietary Supplements , Disease Models, Animal , Glutathione/analysis , Glutathione/metabolism , Hippocampus/immunology , Hippocampus/metabolism , Hippocampus/pathology , Humans , Inflammation/diet therapy , Inflammation/immunology , Insulin Resistance , Liver/pathology , Male , Mice , Mice, Obese , Obesity/immunology , Obesity/metabolism , Obesity/pathology , Transforming Growth Factor beta1/analysis , Transforming Growth Factor beta1/metabolism
2.
Article in English | MEDLINE | ID: mdl-33031994

ABSTRACT

As the infected cases of COVID-19 reach more than 20 million with more than 778,000 deaths globally, an increase in psychiatric disorders including anxiety and depression has been reported. Scientists globally have been searching for novel therapies and vaccines to fight against COVID-19. Improving innate immunity has been suggested to block progression of COVID-19 at early stages, while omega-3 polyunsaturated fatty acids (n-3 PUFAs) have been shown to have immunomodulation effects. Moreover, n-3 PUFAs have also been shown to improve mood disorders, thus, future research is warranted to test if n-3 PUFAs may have the potential to improve our immunity to counteract both physical and mental impact of COVID-19.


Subject(s)
Anxiety/prevention & control , Coronavirus Infections/prevention & control , Depression/prevention & control , Dietary Supplements , Fatty Acids, Omega-3/administration & dosage , Immunologic Factors/administration & dosage , Pandemics/prevention & control , Pneumonia, Viral/prevention & control , Anxiety/immunology , Anxiety/metabolism , Anxiety/virology , Betacoronavirus/immunology , Betacoronavirus/pathogenicity , COVID-19 , Coronavirus Infections/immunology , Coronavirus Infections/metabolism , Coronavirus Infections/virology , Cytokines/biosynthesis , Cytokines/immunology , Dendritic Cells/drug effects , Dendritic Cells/immunology , Dendritic Cells/virology , Depression/immunology , Depression/metabolism , Depression/virology , Epithelial Cells/drug effects , Epithelial Cells/immunology , Epithelial Cells/virology , Fatty Acids, Omega-3/immunology , Fatty Acids, Omega-3/metabolism , Host-Pathogen Interactions/drug effects , Host-Pathogen Interactions/immunology , Humans , Immunity, Innate/drug effects , Immunologic Factors/immunology , Immunologic Factors/metabolism , Lymphocytes/drug effects , Lymphocytes/immunology , Lymphocytes/virology , Macrophages/drug effects , Macrophages/immunology , Macrophages/virology , Pneumonia, Viral/immunology , Pneumonia, Viral/metabolism , Pneumonia, Viral/virology , SARS-CoV-2
3.
Aging (Albany NY) ; 12(11): 10457-10472, 2020 05 20.
Article in English | MEDLINE | ID: mdl-32433038

ABSTRACT

Sleep disorder has become a prevalent issue in current society and is connected with the deterioration of neurobehaviors such as mood, cognition and memory. Ellagic acid (EA) is a phenolic phytoconstituent extracted from grains and fruits that has potent neuroprotective properties. This research aimed to study the alleviative effect and mechanism of EA on memory impairment and anxiety caused by sleep deprivation (SD). EA ameliorated behavioral abnormalities in SD mice, associated with increased dendritic spine density, and reduced shrinkage and loss of hippocampal neurons. EA reduced the inflammatory response and oxidative stress injury caused by SD, which may be related to activation of the Nrf2/HO-1 pathway and mitigation of the TLR4-induced inflammatory response. In addition, EA significantly reduced the mortality and ROS levels in glutamate (Glu)-induced hippocampal neuron injury, and these effects of EA were enhanced in TLR4 siRNA-transfected neurons. However, knockdown of Nrf2 dramatically restrained the protective impact of EA on Glu-induced toxicity. Taken together, EA alleviated memory impairment and anxiety in sleep-deprived mice potentially by inhibiting TLR4 and activating Nrf2. Our findings suggested that EA may be a promising nutraceutical ingredient to prevent cognitive impairment and anxiety caused by sleep loss.


Subject(s)
Anxiety/prevention & control , Cognitive Dysfunction/prevention & control , Ellagic Acid/administration & dosage , Neuroprotective Agents/administration & dosage , Sleep Deprivation/complications , Animals , Anxiety/immunology , Anxiety/pathology , Cells, Cultured , Cognitive Dysfunction/immunology , Cognitive Dysfunction/pathology , Dietary Supplements , Disease Models, Animal , Gene Knockdown Techniques , Hippocampus/immunology , Hippocampus/metabolism , Hippocampus/pathology , Humans , Male , Mice , NF-E2-Related Factor 2/agonists , NF-E2-Related Factor 2/genetics , NF-E2-Related Factor 2/metabolism , Neurons/immunology , Neurons/metabolism , Neurons/pathology , Oxidative Stress/drug effects , Primary Cell Culture , Reactive Oxygen Species/metabolism , Sleep Deprivation/diet therapy , Sleep Deprivation/immunology , Sleep Deprivation/pathology , Toll-Like Receptor 4/antagonists & inhibitors , Toll-Like Receptor 4/metabolism
4.
Brain Behav Immun ; 87: 34-39, 2020 07.
Article in English | MEDLINE | ID: mdl-32298803

ABSTRACT

The coronavirus disease 19 (COVID-19) pandemic is a significant psychological stressor in addition to its tremendous impact on every facet of individuals' lives and organizations in virtually all social and economic sectors worldwide. Fear of illness and uncertainty about the future precipitate anxiety- and stress-related disorders, and several groups have rightfully called for the creation and dissemination of robust mental health screening and treatment programs for the general public and front-line healthcare workers. However, in addition to pandemic-associated psychological distress, the direct effects of the virus itself (several acute respiratory syndrome coronavirus; SARS-CoV-2), and the subsequent host immunologic response, on the human central nervous system (CNS) and related outcomes are unknown. We discuss currently available evidence of COVID-19 related neuropsychiatric sequelae while drawing parallels to past viral pandemic-related outcomes. Past pandemics have demonstrated that diverse types of neuropsychiatric symptoms, such as encephalopathy, mood changes, psychosis, neuromuscular dysfunction, or demyelinating processes, may accompany acute viral infection, or may follow infection by weeks, months, or longer in recovered patients. The potential mechanisms are also discussed, including viral and immunological underpinnings. Therefore, prospective neuropsychiatric monitoring of individuals exposed to SARS-CoV-2 at various points in the life course, as well as their neuroimmune status, are needed to fully understand the long-term impact of COVID-19, and to establish a framework for integrating psychoneuroimmunology into epidemiologic studies of pandemics.


Subject(s)
Coronavirus Infections/psychology , Cytokine Release Syndrome/psychology , Mental Disorders/psychology , Nervous System Diseases/psychology , Pneumonia, Viral/psychology , Acute Disease , Anxiety/etiology , Anxiety/immunology , Anxiety/psychology , Bacterial Translocation , Betacoronavirus , COVID-19 , Chronic Disease , Coronavirus Infections/complications , Coronavirus Infections/immunology , Coronavirus Infections/therapy , Cytokine Release Syndrome/immunology , Cytokine Release Syndrome/therapy , Demyelinating Diseases/etiology , Demyelinating Diseases/immunology , Demyelinating Diseases/physiopathology , Demyelinating Diseases/psychology , Depression/etiology , Depression/immunology , Depression/psychology , Humans , Immunologic Factors/adverse effects , Mental Disorders/etiology , Mental Disorders/immunology , Mental Health , Nervous System Diseases/etiology , Nervous System Diseases/immunology , Nervous System Diseases/physiopathology , Neurodegenerative Diseases/etiology , Neurodegenerative Diseases/immunology , Neurodegenerative Diseases/physiopathology , Neurodegenerative Diseases/psychology , Pandemics , Pneumonia, Viral/complications , Pneumonia, Viral/immunology , Pneumonia, Viral/therapy , Psychoneuroimmunology , Psychotic Disorders/etiology , Psychotic Disorders/immunology , Psychotic Disorders/psychology , Public Health , SARS-CoV-2 , Stress Disorders, Post-Traumatic/etiology , Stress Disorders, Post-Traumatic/immunology , Stress Disorders, Post-Traumatic/psychology
5.
Brain Behav Immun ; 87: 8-9, 2020 07.
Article in English | MEDLINE | ID: mdl-32334064

ABSTRACT

The COVID-19 pandemic has led to high levels of psychological distress in the general public, including symptoms of anxiety and depression. Such distress is associated with alterations in immune function, including an elevated risk of viral respiratory tract infections. In this light, the possible effects of Ayurveda, a traditional system of medicine promoted by the Indian government as an "immune booster", are examined from the point of view of psychoneuroimmune mechanisms as well as the "meaning response" described by Moerman. It was found that many of the measures advocated in their guidelines could positively influence immunity either by direct effects on symptoms of depression or anxiety, or through their symbolic significance. Therefore, it is possible that such traditional practices could be beneficial both in terms of psychological quality of life, and in terms of moderating the risk of infection.


Subject(s)
Anxiety/immunology , Coronavirus Infections/epidemiology , Depression/immunology , Medicine, Ayurvedic , Pneumonia, Viral/epidemiology , Psychoneuroimmunology , Stress, Psychological/immunology , Anxiety/epidemiology , Anxiety/psychology , Betacoronavirus , COVID-19 , Coriandrum , Cuminum , Curcuma , Depression/epidemiology , Depression/psychology , Garlic , Guidelines as Topic , Humans , India/epidemiology , Pandemics , Plant Preparations , Psychological Distress , SARS-CoV-2 , Spices , Stress, Psychological/epidemiology , Stress, Psychological/psychology , Teas, Herbal , Yoga
6.
Food Funct ; 9(8): 4457-4468, 2018 Aug 15.
Article in English | MEDLINE | ID: mdl-30073231

ABSTRACT

The gastroprotective effect of Ocimum basilicum L. (Basil) hexane extract (OBHE) in aspirin-induced gastric ulcers in mice and its ameliorative effect on behavioral alterations were determined. Pretreatment with OBHE (100 or 200 mg kg-1) or misoprostol (50 µg kg-1) alleviated the aspirin-induced oxidative stress by significantly decreasing (p < 0.001) gastric ulcer index scores (57, 76 and 79%), gastric TBARS (by 49, 51 and 52%), NO (21, 28 and 29%), H2O2 (24, 42 and 45%), and the serum pro-inflammatory mediator TNF-α (21, 53 and 53%) and IL-6 (29, 30 and 31%), as well as by markedly increasing gastric GSH (41, 61 and 70%), GSH-Px (21, 32 and 34%), GST (33, 63 and 70%), GR (90, 99 and 112%), CAT (167, 211 and 267%) and serum PGE-2 levels (22, 135 and 200%) and IL-4 (64, 81 and 104%), respectively, compared with the aspirin-treated group. Meanwhile, OBHE and misoprostol induced a significant decrease (p < 0.001) in the freezing time (53, 56 and 64%), and the grooming time (by 25, 43 and 44%), respectively, compared to the aspirin treated group. This study provides evidence that OBHE confers anxiolytic, antioxidant and anti-inflammatory prophylactic effects on aspirin-induced gastric ulcers. GC/MS was used for the characterization of OBHE components. Based on the findings of this study, basil may be used as a nutritional supplement or therapeutic drug to protect against aspirin-induced gastric ulcers, a common problem resulting from the use of aspirin.


Subject(s)
Anxiety/drug therapy , Aspirin/adverse effects , Ocimum basilicum/chemistry , Oxidative Stress/drug effects , Plant Extracts/administration & dosage , Protective Agents/administration & dosage , Stomach Ulcer/prevention & control , Animals , Anxiety/etiology , Anxiety/genetics , Anxiety/immunology , Behavior, Animal/drug effects , Female , Humans , Interleukin-4/genetics , Interleukin-4/immunology , Interleukin-6/genetics , Interleukin-6/immunology , Male , Mice , Motor Activity/drug effects , Plant Leaves/chemistry , Stomach Ulcer/chemically induced , Stomach Ulcer/immunology , Stomach Ulcer/metabolism , Tumor Necrosis Factor-alpha/genetics , Tumor Necrosis Factor-alpha/immunology
7.
Methods Mol Biol ; 1781: 77-85, 2018.
Article in English | MEDLINE | ID: mdl-29705843

ABSTRACT

Evidences from psychoneuroimmunology (PNI) and systems biology studies support a conceptual framework of "Yin-Yang dynamics" for understanding the "whole mind-body system." The Yin-Yang dynamical balances in the stress response networks may be critical for health and diseases, especially mental health and psychiatric disorders. Specifically, the neuroimmune imbalances have been found as the important features and potential biomarkers of stress, anxiety, depression, and systemic inflammation. At the system levels, factors such as psychosocial stress and obesity, especially a leaky gut, may result in the imbalance between regulatory and proinflammatory T cells. At the molecular and cellular levels, the imbalances in multiple networks including the cytokine and redox pathways, immune-kynurenine networks, HPA axis, and synaptic plasticity in the hypothalamus are the key factors in depression. The recognition of the neuroimmune imbalances and the restoration of the Yin-Yang dynamical balances need to become a high priority toward the development of dynamical systems medicine for psychiatric diseases including depression and schizophrenia.


Subject(s)
Anxiety/prevention & control , Depression/prevention & control , Precision Medicine , Psychoneuroimmunology , Stress, Physiological/immunology , Yin-Yang , Anxiety/immunology , Depression/immunology , Humans
8.
Dev Psychobiol ; 60(2): 202-215, 2018 03.
Article in English | MEDLINE | ID: mdl-29171012

ABSTRACT

Anxiety can impact the immune system resulting in negative health outcomes. Salivary immunoglobulin A (sIgA) is a first line of defense against foreign antigens, with lowered levels indicative of weakened mucosal immunity. Little is known about how anxiety symptoms affect the diurnal rhythm of sIgA secretion, or the longitudinal transactional sequence between the two in children and adolescents. The goals of the two studies were to: (i) explore the concurrent associations between self-reported anxiety symptoms and diurnal variations of sIgA across the day using repeated daily samples of sIgA; and (ii) examine transactional relations between children's anxiety and aggregated total amount of sIgA levels across successive periods from middle childhood (Wave 1; ages 9-12) to early adolescence (Wave 2; ages 12-15), and from early to mid- adolescence (Wave 3; ages 15-18). Concurrent results showed a steeper (positive) rise in diurnal slope of sIgA from awakening to 5 hr post-awakening in children with higher anxiety. Longitudinally, higher levels of total anxiety, and specifically, worries at Wave 1 significantly predicted lower cumulative daily levels of sIgA 3 years later at Wave 2. Lowered sIgA levels at Wave 2 in turn predicted higher anxiety at Wave 3, illustrating a "vicious cycle" feedback loop. These findings broaden our understanding of the developmental links between anxiety symptoms, the immune system, and health.


Subject(s)
Anxiety , Circadian Rhythm/physiology , Immunoglobulin A, Secretory/analysis , Saliva/immunology , Adolescent , Anxiety/immunology , Anxiety/metabolism , Anxiety/physiopathology , Child , Female , Follow-Up Studies , Humans , Male
9.
Arch Physiol Biochem ; 124(4): 306-312, 2018 Oct.
Article in English | MEDLINE | ID: mdl-29113509

ABSTRACT

CONTEXT: We have previously shown that an antidepressant-like effect of probiotics in rats was associated with a higher plasma level of the microbial tryptophan metabolite indole-3-propionic acid (IPA). OBJECTIVE: We therefore wanted to study the isolated effect of IPA on behaviour and glucose metabolism in rats. METHODS: Male Sprague-Dawley rats were fed control or IPA-enriched diet for six weeks (n = 12 per group) and assessed in the elevated plus maze, open field and forced swim test. Blood glucose, metabolic hormones and the white blood cell (WBC) composition were analysed. RESULTS: IPA (mean intake 27.3 mg/kg/day) significantly lowered fasting blood glucose level by 0.42 mM (95% CI 0.11-0.73). Similarly, fasting plasma insulin levels and the homeostatic model assessment (HOMA) index of insulin resistance were reduced, whereas plasma metabolic hormones, behaviour and WBC composition remained unaffected by IPA. CONCLUSIONS: Our findings highlight IPA as a promising candidate for treatment of metabolic disorders associated with insulin resistance.


Subject(s)
Dietary Supplements , Hyperinsulinism/prevention & control , Hypoglycemic Agents/therapeutic use , Indoles/therapeutic use , Insulin Resistance , Prediabetic State/prevention & control , Propionates/therapeutic use , Animals , Anxiety/blood , Anxiety/immunology , Anxiety/metabolism , Anxiety/prevention & control , Behavior, Animal , Blood Glucose/analysis , Depression/blood , Depression/immunology , Depression/metabolism , Depression/prevention & control , Diabetes Mellitus, Type 2/blood , Diabetes Mellitus, Type 2/immunology , Diabetes Mellitus, Type 2/metabolism , Diabetes Mellitus, Type 2/prevention & control , Dietary Supplements/adverse effects , Hyperinsulinism/blood , Hyperinsulinism/immunology , Hyperinsulinism/metabolism , Hypoglycemic Agents/adverse effects , Indoles/adverse effects , Insulin/blood , Leukocyte Count , Male , Prediabetic State/blood , Prediabetic State/immunology , Prediabetic State/metabolism , Propionates/adverse effects , Random Allocation , Rats, Sprague-Dawley
10.
Proc Natl Acad Sci U S A ; 114(47): 12554-12559, 2017 11 21.
Article in English | MEDLINE | ID: mdl-29109260

ABSTRACT

Adverse social conditions have been linked to a conserved transcriptional response to adversity (CTRA) in circulating leukocytes that may contribute to social gradients in disease. However, the CNS mechanisms involved remain obscure, in part because CTRA gene-expression profiles often track external social-environmental variables more closely than they do self-reported internal affective states such as stress, depression, or anxiety. This study examined the possibility that variations in patterns of natural language use might provide more sensitive indicators of the automatic threat-detection and -response systems that proximally regulate autonomic induction of the CTRA. In 22,627 audio samples of natural speech sampled from the daily interactions of 143 healthy adults, both total language output and patterns of function-word use covaried with CTRA gene expression. These language features predicted CTRA gene expression substantially better than did conventional self-report measures of stress, depression, and anxiety and did so independently of demographic and behavioral factors (age, sex, race, smoking, body mass index) and leukocyte subset distributions. This predictive relationship held when language and gene expression were sampled more than a week apart, suggesting that associations reflect stable individual differences or chronic life circumstances. Given the observed relationship between personal expression and gene expression, patterns of natural language use may provide a useful behavioral indicator of nonconsciously evaluated well-being (implicit safety vs. threat) that is distinct from conscious affective experience and more closely tracks the neurobiological processes involved in peripheral gene regulation.


Subject(s)
Anxiety/genetics , Depression/genetics , Leukocytes/immunology , Speech , Stress, Psychological/genetics , Adult , Anxiety/diagnosis , Anxiety/immunology , Anxiety/physiopathology , Depression/diagnosis , Depression/immunology , Depression/physiopathology , Female , Gene Expression Profiling , Gene Expression Regulation , Humans , Immune System , Language , Leukocytes/pathology , Male , Middle Aged , Natural Language Processing , Stress, Psychological/diagnosis , Stress, Psychological/immunology , Stress, Psychological/physiopathology
11.
Neuroscience ; 357: 241-254, 2017 08 15.
Article in English | MEDLINE | ID: mdl-28627418

ABSTRACT

Elevated levels of oxidative stress and neuronal inflammation in the hypothalamus or ventral midbrain, respectively, represent common denominators for obesity and Parkinson's Disease (PD). However, little is known about defense mechanisms that protect neurons in these regions from oxidative damage. Here, we aimed to assess whether murine Gpx4, a crucial antioxidant enzyme that protects neurons from membrane damage and ferroptosis, is critical for the protection from neuronal inflammation in two distinct pathophysiologic diseases, namely metabolic dysfunction in diet-induced obesity or PD. Gpx4 was deleted from either AgRP or POMC neurons in the hypothalamus, essential for metabolic homeostasis, or from dopaminergic neurons in the ventral midbrain, governing behaviors such as anxiety or voluntary movement. To induce a pro-inflammatory environment, AgRP and POMC neuron-specific Gpx4 knockout mice were subjected to high-fat high-sucrose (HFHS) diet. To exacerbate oxidative stress in dopaminergic neurons of the ventral midbrain, we systemically co-deleted the PD-related gene DJ-1. Gpx4 was dispensable for the maintenance of cellular health and function of POMC neurons, even in mice exposed to obesogenic conditions. In contrast, HFHS-fed mice with Gpx4 deletion from AgRP neurons displayed increased body adiposity. Gpx4 expression and activity were diminished in the hypothalamus of HFHS-fed mice compared to standard diet-fed controls. Gpx4 deletion from dopaminergic neurons induced anxiety behavior, and diminished spontaneous locomotor activity when DJ-1 was co-deleted. Overall, these data suggest a physiological role for Gpx4 in balancing metabolic control signals and inflammation in AgRP but not POMC neurons. Moreover, Gpx4 appears to constitute an important rheostat against neuronal dysfunction and PD-like symptoms in dopaminergic circuitry within the ventral midbrain.


Subject(s)
Anxiety/enzymology , Body Weight/physiology , Glutathione Peroxidase/deficiency , Motor Activity/physiology , Obesity/enzymology , Parkinsonian Disorders/enzymology , Adiposity/physiology , Animals , Anxiety/immunology , Anxiety/pathology , Behavior, Animal/physiology , Diet, High-Fat , Dietary Sucrose , Dopaminergic Neurons/enzymology , Dopaminergic Neurons/immunology , Dopaminergic Neurons/pathology , Female , Glutathione Peroxidase/genetics , Glutathione Peroxidase/metabolism , Hypothalamus/enzymology , Hypothalamus/immunology , Hypothalamus/pathology , Male , Mice, Inbred C57BL , Mice, Knockout , Obesity/pathology , Oxidative Stress/physiology , Parkinsonian Disorders/immunology , Parkinsonian Disorders/pathology , Phospholipid Hydroperoxide Glutathione Peroxidase , Protein Deglycase DJ-1/genetics , Protein Deglycase DJ-1/metabolism , Sex Characteristics , Glutathione Peroxidase GPX1
12.
Brain Behav Immun ; 65: 202-209, 2017 Oct.
Article in English | MEDLINE | ID: mdl-28495610

ABSTRACT

A growing number of studies show an association between seasonal allergic rhinitis (SAR) with depression and anxiety. The underlying mechanisms of a link between SAR and affect, however, are still unclear. The objective of the present study was to investigate depressive symptoms and anxiety in SAR patients and their association to inflammatory and endocrine parameters. SAR patients (n=41) and non-allergic, healthy controls (n=42) were assessed during (pollen season) and out of symptomatic periods (non-pollen season). Inflammatory cytokine profile (Interleukin [IL]-2, IL-4, IL-6, IL-8, IL-10, IL-17, IFN-γ, TNF-α), Immunoglobulin-E (IgE), hair cortisol concentrations (HCC), as well as sleep quality were measured. The present data show that during acute allergic inflammation SAR patients experienced a significant increase in Beck Depression Inventory (BDI-) II scores when (a) compared to the asymptomatic period and (b) when compared to the non-allergic controls, while no differences in anxiety were observed. Increased BDI-II scores in SAR patients were significantly associated with levels of IL-6 as well as IL-6/IL-10 and IFN-γ/IL-10 ratios and further, to an early age at manifestation of SAR and poor sleep quality. These findings support a close relationship between acute allergic processes and affective states, with inflammatory cytokines, sleep, and age of manifestation as potentially relevant mediators.


Subject(s)
Depression/immunology , Rhinitis, Allergic, Seasonal/immunology , Rhinitis, Allergic, Seasonal/psychology , Adult , Affect , Allergens/metabolism , Anxiety/etiology , Anxiety/immunology , Biomarkers/blood , Depression/etiology , Female , Humans , Hypersensitivity , Immunoglobulin E/immunology , Immunoglobulin E/metabolism , Inflammation/immunology , Inflammation/metabolism , Interferon-gamma/metabolism , Interleukin-10/metabolism , Interleukin-6/metabolism , Male , Pollen , Rhinitis, Allergic, Seasonal/metabolism , Tumor Necrosis Factor-alpha/immunology , Tumor Necrosis Factor-alpha/metabolism
13.
Vitam Horm ; 103: 1-25, 2017.
Article in English | MEDLINE | ID: mdl-28061967

ABSTRACT

Stress and stressful events are common occurrences in our daily lives and such aversive situations bring about complex changes in the biological system. Such stress responses influence the brain and behavior, neuroendocrine and immune systems, and these responses orchestrate to increase or decrease the ability of the organism to cope with such stressors. The brain via expression of complex behavioral paradigms controls peripheral responses to stress and a bidirectional link exists in the modulation of stress effects. Anxiety is a common neurobehavioral correlate of a variety of stressors, and both acute and chronic stress exposure could precipitate anxiety disorders. Psychoneuroimmunology involves interactions between the brain and the immune system, and it is now being increasingly recognized that the immune system could contribute to the neurobehavioral responses to stress. Studies have shown that the brain and its complex neurotransmitter networks could influence immune function, and there could be a possible link between anxiogenesis and immunomodulation during stress. Physiological and pharmacological data have highlighted this concept, and the present review gives an overview of the relationship between stress, anxiety, and immune responsiveness.


Subject(s)
Central Nervous System/immunology , Immunity, Innate , Neuroimmunomodulation , Neurosecretory Systems/immunology , Stress, Physiological/immunology , Stress, Psychological/immunology , Animals , Anti-Anxiety Agents/pharmacology , Anti-Anxiety Agents/therapeutic use , Anxiety/drug therapy , Anxiety/etiology , Anxiety/immunology , Anxiety Disorders/drug therapy , Anxiety Disorders/etiology , Anxiety Disorders/immunology , Central Nervous System/drug effects , Central Nervous System/physiopathology , Humans , Immunity, Innate/drug effects , Immunomodulation/drug effects , Neuroimmunomodulation/drug effects , Neurosecretory Systems/drug effects , Neurosecretory Systems/physiopathology , Stress, Psychological/physiopathology , Stress, Psychological/psychology
14.
J Autoimmun ; 73: 92-9, 2016 09.
Article in English | MEDLINE | ID: mdl-27372915

ABSTRACT

OBJECTIVES: Antiphospholipid syndrome (APS) is associated with neurological manifestations and one of the novel autoantigens associated with this disease is Annexin A2 (ANXA2). In this work we have examined the effect of high levels of autoantibodies to ANXA2 on the brain in a mouse model. METHODS: Recombinant ANXA2 emulsified in adjuvant was used to immunize mice while mice immunized with adjuvant only served as controls. At peak antibody levels the animal underwent behavioral and cognitive tests and their brains were examined for ANXA2 immunoglobulin G (IgG) and expression of ANXA2 and the closely linked protein p11. RESULTS: Very high levels of anti-ANXA2 antibodies (Abs) were associated with reduced anxiety in the open field 13.14% ± 0.89% of the time in the center compared to 8.64% ± 0.91% observed in the control mice (p < 0.001 by t-test). A forced swim test found significantly less depression manifested by immobility in the ANXA2 group. The changes in behavior were accompanied by a significant reduction in serum corticosteroid levels of ANXA2 group compared to controls. Moreover, higher levels of total IgG and p11 expression were found in ANXA2 group brains. Lower levels of circulating anti-ANXA2 Abs were not associated with behavioral changes. CONCLUSIONS: We have established an animal model with high levels of anti-ANXA2 Abs which induced IgG accumulation in the brain and specific anxiolytic and anti-depressive effects. This model promises to further our understanding of autoimmune disease such as APS and to provide better understanding of the role of the ANXA2-p11 complex in the brain.


Subject(s)
Annexin A2/immunology , Antiphospholipid Syndrome/immunology , Antiphospholipid Syndrome/psychology , Anxiety/immunology , Autoantigens/immunology , Autoimmunity , Depression/immunology , Adjuvants, Immunologic/administration & dosage , Adrenal Cortex Hormones/blood , Animals , Annexin A2/metabolism , Anxiety/blood , Anxiety/pathology , Autoantibodies/analysis , Autoantibodies/immunology , Brain/pathology , Depression/blood , Depression/pathology , Disease Models, Animal , Enzyme-Linked Immunosorbent Assay , Female , Humans , Immunoglobulin G/analysis , Immunoglobulin G/immunology , Mice , Mice, Inbred BALB C , Protein Multimerization , Psychological Tests , Recombinant Proteins/immunology , S100 Proteins/metabolism
15.
Brain Behav Immun ; 51: 154-168, 2016 Jan.
Article in English | MEDLINE | ID: mdl-26342944

ABSTRACT

OBJECTIVE: Psychosocial stress is associated with altered immunity, anxiety, and depression. Repeated social defeat (RSD), a model of social stress, triggers egress of inflammatory myeloid progenitor cells (MPCs; CD11b(+)/Ly6C(hi)) that traffic to the brain, promoting anxiety-like behavior. In parallel, RSD enhances neuroinflammatory signaling and long-lasting social avoidant behavior. Lorazepam and clonazepam are routinely prescribed anxiolytics that act by enhancing GABAergic activity in the brain. Besides binding to the central benzodiazepine binding site (CBBS) in the central nervous system (CNS), lorazepam binds to the translocator protein (TSPO) with high affinity causing immunomodulation. Clonazepam targets the CBBS and has low affinity for the TSPO. Here the aims were to determine if lorazepam and clonazepam would: (1) prevent stress-induced peripheral and central inflammatory responses, and (2) block anxiety and social avoidance behavior in mice subjected to RSD. METHODS: C57/BL6 mice were divided into experimental groups, and treated with either lorazepam (0.10mg/kg), clonazepam (0.25mg/kg) or vehicle (0.9% NaCl). Behavioral data and tissues were collected the morning after the last cycle of RSD. RESULTS: Lorazepam and clonazepam were effective in attenuating mRNA expression of CRH in the hypothalamus and corticosterone in plasma in mice subjected to RSD. Both drugs blocked stress-induced levels of IL-6 in plasma. Lorazepam and clonazepam had different effects on stress-induced enhancement of myelopoiesis and inhibited trafficking of monocytes and granulocytes in circulation. Furthermore, lorazepam, but not clonazepam, inhibited splenomegaly and the production of pro-inflammatory cytokines in the spleen following RSD. Additionally, lorazepam and clonazepam, blocked stress-induced accumulation of macrophages (CD11b(+)/CD45(high)) in the CNS. In a similar manner, both lorazepam and clonazepam prevented neuroinflammatory signaling and reversed anxiety-like and depressive-like behavior in mice exposed to RSD. CONCLUSION: These data support the notion that lorazepam and clonazepam, aside from exerting anxiolytic and antidepressant effects, may have therapeutic potential as neuroimmunomodulators during psychosocial stress. The reversal of RSD-induced behavioral outcomes may be due to the enhancement of GABAergic neurotransmission, or some other off-target effect. The peripheral actions of lorazepam, but not clonazepam, seem to be mediated by TSPO activation.


Subject(s)
Anti-Anxiety Agents/administration & dosage , Anxiety/immunology , Brain/drug effects , Brain/immunology , Clonazepam/administration & dosage , GABA Modulators/administration & dosage , Lorazepam/administration & dosage , Stress, Psychological/immunology , Animals , Anxiety/etiology , Behavior, Animal/drug effects , Bone Marrow/drug effects , CD11b Antigen/metabolism , Corticosterone/blood , Corticotropin-Releasing Hormone/metabolism , Granulocytes/drug effects , Hematopoiesis/drug effects , Hippocampus/drug effects , Hippocampus/immunology , Hypothalamus/drug effects , Hypothalamus/immunology , Interleukin-6/blood , Male , Mice , Mice, Inbred C57BL , Microglia/drug effects , Microglia/immunology , Monocytes/drug effects , RNA, Messenger/metabolism , Splenomegaly/etiology , Splenomegaly/prevention & control , Stress, Psychological/complications
16.
Zhen Ci Yan Jiu ; 40(4): 265-9, 2015 Aug.
Article in Chinese | MEDLINE | ID: mdl-26502538

ABSTRACT

OBJECTIVE: To observe the effect of electroacupuncture (EA) intervention on the levels of CD 4+ and CD 8+ lymphocytes in the plasma and thymus in anxiety disorder rats, so as to explore its mechanism underlying favorable regulation of immune function. METHODS: Thirty-four SD rats were randomly divided into control (n = 10) , model (n = 12) and EA (n = 12) groups. The anxiety model was established by using chronic unpredictable emotional stress stimulation (fasting, water-deprivation, shaking, tail-clamping, forced warm- and cool-water swimming, electrical shock stimulation, etc.) for 15 days. EA (15 Hz/ 25 Hz) was applied to "Neiguan" (PC 6) and "Shenmen" (HT 7) for 15 min, once every other day for 15 days. The anxiety-like behavior was measured by elevated plus maze test. Anxiety reduction in the plus-maze is indicated by an increase in the proportion of time spent in the open arms (time in open arms/total time in open or closed arms) , and an increase in the proportion of entries into the open arms (entries into open arms/total entries into open or closed arms). While the contents and expression of CD 4+ and CD 8+ in the plasma and thymus tissues were measured by ELISA and immunohistochemistry, respectively. RESULTS: The values of proportions of open-arm entries (OE%) and the content of plasma CD 4+ lymphocytes were obviously lower in the model group than in the control group (P < 0.05), and were significantly higher in the EA group than in the model group (P < 0.05). Whereas, the content of plasma CD 8+ lymphocytes was obviously higher in the model group than in the control group (P < 0.05) and markedly down-regulated in the EA group after the treatment (P < 0.05). The ratio of CD 4+/CD 8+ was decreased in the model group in comparison with the control group (P = 0.054), and was significantly up-regulated in the EA group after EA stimulation (P < 0.01). Compared with the control group, the expression levels (optical density, OD values) of CD 4+ and CD 8+ lymphocytes in the thymus tissue were obviously decreased in the model group (P < 0.01). After EA, the expression levels of thymus CD 4+ and CD 8+ were remarkably up-regulated in the EA group (P < 0.05). No significant changes were found in proportion of open-arm time (OT%, P > 0.05). CONCLUSION: EA can effectively relieve anxiety disorder in anxiety rats, which may be related to its effects in up-regulating plasma CD 4+ , thymus CD 4+ and CD 8' levels as well as CD 4+/CD 8+ ratio, and down-regulating plasma CD 8+ content.


Subject(s)
Anxiety/therapy , Electroacupuncture , T-Lymphocyte Subsets/immunology , Thymus Gland/immunology , Animals , Anxiety/immunology , Anxiety/psychology , CD4 Lymphocyte Count , Humans , Male , Rats , Rats, Sprague-Dawley , Stress, Psychological
17.
Psychol Trauma ; 7(6): 525-32, 2015 Nov.
Article in English | MEDLINE | ID: mdl-25915646

ABSTRACT

This study examined the effects of a mindfulness-based stress reduction (MBSR) program on psychological functioning and inflammatory biomarkers in women with histories of interpersonal trauma. The 8-week MBSR program was conducted at a community-based health center and participants (N = 50) completed several measures of psychological functioning at study entry as well as 4 weeks, 8 weeks, and 12 weeks later. Inflammatory biomarkers were assayed from blood collected at each assessment. A series of linear mixed-model analyses were conducted to measure the effect of attendance and time on the dependent variables. Time was associated with significant decreases in perceived stress, depression, trait and state anxiety, emotion dysregulation, and posttraumatic stress symptoms, as well as increases in mindfulness. Session attendance was associated with significant decreases in interleukin (IL)-6 levels. This pilot study demonstrated the potential beneficial effects of MBSR on psychological functioning and the inflammatory biomarker IL-6 among trauma-exposed and primarily low-income women. Decreases in inflammation have implications for this population, as interpersonal trauma can instigate chronic physiological dysregulation, heightened morbidity, and premature death. This study's preliminary results support efforts to investigate biological remediation with behavioral interventions in vulnerable populations.


Subject(s)
Interleukin-6/blood , Mindfulness/methods , Stress, Psychological/immunology , Stress, Psychological/therapy , Adult , Anxiety/immunology , Anxiety/therapy , Biomarkers/blood , Blood Chemical Analysis , Depression/immunology , Depression/therapy , Emotional Intelligence , Female , Humans , Interpersonal Relations , Linear Models , Pilot Projects , Self Report , Socioeconomic Factors , Time Factors , Treatment Outcome
19.
Dev Psychopathol ; 26(4 Pt 2): 1567-76, 2014 Nov.
Article in English | MEDLINE | ID: mdl-25422979

ABSTRACT

Research findings in psychoneuroimmunology document reliable, bidirectional linkages among psychological processes, the nervous system, and the immune system. However, available data are based almost entirely on animal and adult human studies; the application to children and adolescents is uncertain. We capitalized on the experimental leverage provided by a routine vaccination to examine the link between mood symptoms and the immune response to a vaccine challenge in early adolescence. One hundred twenty-six 11-year-olds for whom vaccine response data were available were assessed at prevaccination and 4 weeks, 3 months, and 6 months following vaccination; self-report ratings of depression and anxiety as well as measures of psychosocial and somatic risk were assessed prior to vaccine response. Analyses indicated that children's internalizing mood symptoms were associated with elevated and persistently higher antibody responses, with evidence extending to two of the four serogroups. The associations remained after controlling for multiple possible confounders (social class, body mass index, sleep, psychosocial risk, and pubertal status). The observed enhanced vaccine response associated with depressive and anxious symptoms in early adolescence may reflect an important developmental difference in immune system-brain interplay between adults and children, and it underscores the need for further developmental studies of psychoneuroimmunology.


Subject(s)
Anxiety/immunology , Depression/immunology , Meningococcal Vaccines/immunology , Child , Female , Humans , Male
20.
Methods Mol Biol ; 934: 243-76, 2012.
Article in English | MEDLINE | ID: mdl-22933150

ABSTRACT

The field of psychoneuroimmunology (PNI) aims to uncover the processes and consequences of nervous, immune, and endocrine system relationships. Behavior is a consequence of such interactions and manifests from a complex interweave of factors including immune-to-neural and neural-to-immune communication. Often the signaling molecules involved during a particular episode of neuroimmune activation are not known but behavioral response provides evidence that bioactives such as neurotransmitters and cytokines are perturbed. Immunobehavioral phenotyping is a first-line approach when examining the neuroimmune system and its reaction to immune stimulation or suppression. Behavioral response is significantly more sensitive than direct measurement of a single specific bioactive and can quickly and efficiently rule in or out relevance of a particular immune challenge or therapeutic to neuroimmunity. Classically, immunobehavioral research was focused on sickness symptoms related to bacterial infection but neuroimmune activation is now a recognized complication of diseases and disorders ranging from cancer to diabesity. Immunobehaviors include lethargy, loss of appetite, and disinterest in social activity and the surrounding environment. In addition, neuroimmune activation can precipitate feelings of depression and anxiety while negatively impacting cognitive function and physical activity. Provided is a detailed overview of behavioral tests frequently used to examine neuroimmune activation in mice with a special emphasis on preexperimental conditions that can confound or prevent successful immunobehavioral experimentation.


Subject(s)
Psychoneuroimmunology/methods , Animals , Anxiety/immunology , Anxiety/physiopathology , Behavior, Animal , Cognition , Depression/immunology , Depression/physiopathology , Maze Learning , Memory , Mice , Models, Animal , Motor Activity
SELECTION OF CITATIONS
SEARCH DETAIL